Regulatory action was based on data from the Phase III QUASAR trial, which demonstrated that Eylea HD dosed every eight weeks ...

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

US food tech startup Perfect Day has been hit with a false marketing lawsuit for its FDA-approved, animal-free dairy whey ...

Two former FDA leaders look at Commissioner Marty Makary’s early stumbles — and lay out a list of priorities to protect both ...

A novel drug for bloodstream infections, code-named VRP-034 and currently in the development stage pending final trials and ...

The Food and Drug Administration on Thursday cleared a core component of a brain implant made by Precision Neuroscience, a ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

A Neuralink rival backed by a former collaborator of Elon Musk has just received FDA clearance for its brain implant.

The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of ...

Immunome's strong financial position supports ongoing clinical development and potential market entry for key assets. See why ...

Department of Health and Human Services (HHS) reorganization plans appear to have been revealed through a leaked Office of ...